Imagine a world

where
illness is

optional

Mission Possible

In our vision, the future of healthcare is not in hospitals but in the comfort of your home. Tomorrow's medicines won't be found on pharmacy shelves but on a farm.

We believe that by delving deeper into human biology and embracing every individual's unique biochemistry, we can equip you with the knowledge and tools to live longer and thrive.

Viome: A Signal in the Noise

In today's world, generic health advice is everywhere, making it challenging to determine what's best for your well-being. We prioritize understanding your body's specific signals and combine them with scientific evidence to guide your health improvements.

We call our method "a signal in the noise" because we can discern meaningful patterns amidst the vast array of health data within you. With our insights and tools, you can confidently navigate your health, eliminating the confusion surrounding nutrition.

Viome Health
Scores

Expand

Hyper-personalized
Solutions

Expand

Predictive Models To
Further Discovery

Expand

Our Values

Demystify nutrition

We aim to simplify the complexities of the human body and help you make informed decisions about your health based on data.

Address root causes

Our commitment to uncovering root causes and early detection of chronic diseases is what drives us. We’re asking new and better questions, pushing the boundaries of what the world believed to be possible.

Move science forward

Through collaboration across the scientific community, we forge paths to tools and products that directly impact your life. Our Grants Program encourages collaborative research across the scientific community. Together, we're building solutions that can save and improve lives, including yours.

Create evidence-based, actionable solutions

Your Health Scores, food recommendations, and personalized health products represent and are made for your individual biology, supporting your needs today and your needs as you evolve. With data from over 600,000 samples and thousands of third-party clinical study references, your personalized recommendations and formula ingredients are based on extensive research.

Return value to every user through our discoveries

Our mission is you. Every insight, every breakthrough is about you. The knowledge we gain from our studies and customer interactions feeds back into our platform, training our AI to serve you better. You're not just on the receiving end of our discoveries; you're at the heart of them.

Protect privacy

At Viome, we safeguard your data with advanced encryption methods and keep your identity separate from your health details. We do not share your information with employers or health insurers. We do not sell your data to third parties.

Our Ecosystem

At Viome, our ecosystem encompasses leading scientists, entrepreneurs, clinicians, and academics specialized in microbiology, clinical practice, epigenetics, systems biology, AI & data science, and bioinformatics. United, our multidisciplinary team of pioneering scientists and seasoned executive leadership collaboratively tackles some of the most daunting unaddressed medical challenges.

Leadership Team

Naveen Jain

Founder & CEO

Naveen Jain is a serial entrepreneur and philanthropist driven to solve the world's biggest challenges through innovation. From local boy to lunar visionary, Naveen sees beyond the current business and technological landscape, creating companies that make a true impact. As the founder of Moon Express, World Innovation Institute, TalentWise, Intelius, and Infospace, Naveen is an intensely curious entrepreneur who is focused on audacious ideas that push humanity forward.

Learn more at NaveenJain.com

Guruduth Banavar, PhD

Founding CTO & Head of Discovery AI

Guru is a leader in Artificial Intelligence known for his work on Host/Microbe Molecular Data Analysis, IBM Watson AI Systems, Smarter Cities, Services Innovation, Mobile Computing, and Distributed Systems. As founding CTO at Viome Life Sciences, he leads AI and co-leads clinical research.

Let's connect

Momo Vuyisich, PhD

Founding CSO & Head of Clinical Research

Momo is an entrepreneur-scientist with over 25 years of R&D experience in biology, chemistry, and bioinformatics. He has led large programs, from ideas to successful commercial products.

Let's connect

Stephen Barrie, ND, PhD

VP & Head of Clinical Nutrition

Dr. Barrie is an internationally recognized physician, clinical medical researcher, lecturer, inventor, author, and entrepreneur, and one of the founding pioneers in the microbiome field. He is the founder and former CEO & Chairman of Genova Diagnostics, the world’s largest Functional Medicine clinical reference laboratory for physicians.

Let's connect

Sarah Dorsett

President, Viome Life Sciences, Consumer

Sarah Dorsett, former CEO of Nanit, is a seasoned business leader known for scaling high-growth retail ventures across diverse consumer product domains. With over two decades in e-commerce, she's acclaimed for her roles, including Vice President of E-commerce at Bed Bath & Beyond, Coty, Bloomingdales, and Century 21.

Let's connect

Helene Vollbracht

Chief Product Strategy Officer, Corporate Brand & Communications

Helene leads Viome’s product strategy and corporate brand positioning, driving innovative product development and strategic product partnerships that amplify Viome’s pioneering science and technology. With expertise spanning brand marketing, behavioral science, entertainment, and public relations, she shapes compelling customer experiences and elevates Viome’s position as a global leader in personalized health and precision nutrition.

Let's connect

Damon Tanton, MD

Chief Medical Officer

Dr. Tanton is an endocrinologist and obesity medicine specialist who oversees the inpatient and outpatient endocrine care across nine clinical campuses. His team conducts over 125,000 patient visits per year, and has been recognized by US News and World Report as one of the top 15 endocrinology programs in the nation. Damon serves as a national strategy consultant and an international speaker on insulin resistance and other metabolic diseases.

Scientific & Business Advisory Board

Alessio Fasano, MD

W. Allan Walker Chair of Pediatric Gastroenterology and Nutrition, Professor of Pediatrics, Harvard Medical School, Chief of Division of Pediatric Gastroenterology and Nutrition.

Andrew McCallum, PhD

Andrew McCallum is Professor and Director of the Information Extraction and Synthesis Laboratory, as well as Director of Center for Data Science in the College of Information and Computer Science at University of Massachusetts Amherst.

Salomon Amar, D.D.S., Ph.D.

Salomon Amar, D.D.S., Ph.D., is vice president for research at New York Medical College and director of the office of research administration. Dr. Amar holds academic appointments as professor of pharmacology and professor of microbiology and immunology at NYMC.

George Church, PhD

George is Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology (MIT). He is Director of the U.S. Department of Energy Technology Center and Director of the National Institutes of Health Center of Excellence in Genomic Science.

Umadevi Naidoo, MBCHB

Umadevi the Director of Nutritional and Metabolic Psychiatry at Massachusetts General Hospital & Director of Nutritional Psychiatry at the MGH Academy while serving on the faculty at Harvard Medical School.

Ed Zuckerberg, DDS, FAGD

Dr. Edward Zuckerberg has been a pioneer in the integration of technology in the dental office and development of techniques for delivering painless dentistry for over 30 years. He continues the advancement of newer dental technologies through lecturing at dental conferences and conventions.

Sanjiv Chopra, MD

Sanjiv Chopra, MD, is a Professor of Medicine and served as Faculty Dean for Continuing Medical Education at Harvard Medical School for 12 years. He serves as a Marshall Wolf Master Clinician Educator Brigham and Women’s Hospital.

Board of Directors

Naveen Jain

Teymour Boutros-Ghali

Founder of several successful technology companies, Teymour brings more than 30 years of investment experience to BOLD. Teymour is co-founder and Managing Partner of BOLD and was previously General Partner of Monitor Ventures (an early stage venture fund), and Vice President of Time Inc. Ventures (Time Inc.’s corporate Venture fund). A graduate of Cambridge University in EE with a PhD from MIT, he has a deep interest in disruptive technologies and has lectured on entrepreneurship at UCLA.

Erik Anderson

Erik Anderson is a leader in global innovation recognized throughout his career for his business acumen and leadership. As the Founder and Chief Executive Officer of WestRiver Group (WRG), Anderson is redefining the paradigm of capital allocation with a transformative business model.

Chris Kitze

Chris Kitze is a technology innovator and investor. As a serial entrepreneur, he has created companies with over $7 billion of market capitalization during a 25-year career. He was part of the Lycos’ IPO team, and founder and CEO of Xoom.com (IPO: 1998), and was CEO of NBCi, formed by the merger of Xoom.com and Snap.com, in addition to other companies in digital communications, media and payments.

Bill Owens

Former Vice-Chairman of the Joint Chief of Staff of the United States of America, CEO of Nortel Telecommunications, Vice-Chairman for NYSE Asia, and Chairman and Senior Partner of AEA Investors Asia. Admiral Owens was also Chairman of Eastern Airlines and served on over 25 public boards including Daimler, British American Tobacco, Telstra, Nortel Networks, and Polycom.

"As we uncover the microbiome's significant role in chronic diseases and aging, Viome's methodology stands out. By analyzing gene expression of both the human and microbial genome, Viome not only discerns the root causes of various diseases but also pioneers a personalized nutrition strategy based on these insights. Their approach promises a future where we can both prevent and reverse chronic ailments."

George Church

Professor of Genetics at Harvard Medical School & Professor of Health Sciences and Technology at Harvard and MIT

“The future of healthcare is individual and personalized, and few companies have been driving innovation in this space as rapidly as Viome. Through the company’s continued research, development, and advancements, Viome is bringing us one step closer to a healthier world.”

Vinod Khosla

Founder & CEO of Khosla Ventures

"The world of microbiome studies is at a crossroad, trying to capitalize on years of science to move from descriptive studies to more causative evidence in order to implement personalized interventions or preventive measures, manipulating the microbiome to our advantage. Viome is among the companies leading this effort using cutting age tools for microbiome analysis and interpretation to tailor nutrition recommendations."

Alessio Fasano

Professor and Director of the Mucosal Immunology and Biology Research Center at Massachusetts General Hospital

"Viome is breaking new ground in developing precision recommendations of foods and supplements, and studying how these interventions can improve a range of biological processes, especially related to digestion and mood. They are not only discovering the mechanisms underlying human health, but also developing new methods for improving health through the use of precision supplements."

Emeran Mayer

Physician-scientist, UCLA Professor of Medicine, Physiology and Psychiatry

1 / 4

Investors